New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cardiol Therapeutics Inc.
CRDL
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

132M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

132M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

1.90USD
Shape-0.01 ( -0.79%)
Market Open
favorite-chart

Relative Strenght

98
favorite-chart

Volume Buzz

-61%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

39%

Quote Panel

Shape
Updated October 16, 2024
1W 6.46 % 1M -11.45 % 3M -10.19 % 1Y 131.38 %

Key Metrics

Shape
  • Market Cap

    132.43M


  • Shares Outstanding

    69.88M


  • Share in Float

    66.31M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    1.895


  • Average Volume

    412167


  • Beta

    0.697


  • Range

    0.661-3.12


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.cardiolrx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

11.67x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-0.3

EPS

How CRDL compares to sector?

P/E Ratio

Relative Strength

Shape

CRDL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$0.55

Shape-478%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

B. Riley

initialise

Previous: Not converted

2024-06-26

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.10
vs -0.18

Q4.22

arrow
arrow

N/A

-0.09
vs -0.09

Q1.23

arrow
arrow

N/A

-0.08
vs -0.11

Q2.23

arrow
arrow

N/A

-0.09
vs -0.08

Q3.23

arrow
arrow

N/A

-0.07
vs -0.10

Q4.23

arrow
arrow

N/A

-0.09
vs -0.09

Q1.24

arrow
arrow

N/A

-0.10
vs -0.08

Q2.24

arrow
arrow

N/A

-0.07
vs -0.09

Q3.24

arrow
arrow

N/A

-0.08
vs -0.07

Q4.24

arrow
arrow

N/A

-0.07
vs -0.09

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

-100%

NA  vs 78.8K

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-14%

-0.14
vs -0.10

Q4.22

arrow
arrow

-14%

-0.14
vs -0.14

Q1.23

arrow
arrow

-16%

-0.16
vs -0.14

Q2.23

arrow
arrow

-19%

-0.19
vs -0.16

Q3.23

arrow
arrow

-17%

-0.17
vs -0.19

Q4.23

arrow
arrow

-27%

-0.27
vs -0.17

Q1.24

arrow
arrow

-46%

-0.46
vs -0.27

Q2.24

arrow
arrow

-43%

-0.43
vs -0.46

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

28

28
vs 29

-3%

Q4.22

arrow
arrow

32

32
vs 28

14%

Q1.23

arrow
arrow

33

33
vs 32

3%

Q2.23

arrow
arrow

32

32
vs 33

-3%

Q3.23

arrow
arrow

34

34
vs 32

6%

Q4.23

arrow
arrow

35

35
vs 34

3%

Q1.24

arrow
arrow

37

37
vs 35

6%

Q2.24

arrow
arrow

43

43
vs 37

16%

Earnings Growth

Latest News